FDA to weigh easing limits on unproven peptides favored by RFK Jr. and MAHA supporters PBS News FDA issued its first warning letter to a dispenser (a medical spa) for violating the Drug Supply Chain Security Act (DSCSA), including failing to source products from authorized trading partners and FDA Compliance for Peptide Therapy and BPC 157 Holt Law The peptide problem: Hype is outrunning the evidence of the Federal Food, Drug, and Cosmetic Act (FDCA).* Peptides Lack Reliable Safety Information, Watchdog Warns